Director/PDMR Shareholding
16 February 2011
Barclays PLC
Director/PDMR shareholding: Disclosure and Transparency Rules 3.1.4R(1)(a)
On 15 February 2011 the following ordinary shares in Barclays PLC ("the Company") were purchased on behalf of the following non-executive Directors of the Company at a price of £3.2210 per share. As disclosed in the Company's Annual Report, these purchases arise from the policy of using part of each non-executive Director's fee to purchase shares in the Company on the Directors' behalf which, together with any reinvested dividends, are retained for the Director until they leave the Board.
|
DIRECTOR
|
BARCLAYS PLC SHARES PURCHASED |
TOTAL BENEFICIAL INTEREST FOLLOWING THIS NOTIFICATION |
TOTAL NON-BENEFICIAL INTEREST FOLLOWING THIS NOTIFICATION
|
|
David Booth |
1,935 |
79,220 |
- |
|
Sir Richard Broadbent |
1,952 |
40,729 |
- |
|
Alison Carnwath |
1,203 |
41,203 |
- |
|
Fulvio Conti |
1,866 |
44,836 |
- |
|
Simon Fraser |
1,815 |
51,583 |
- |
|
Reuben Jeffery¹ |
2,447 |
67,691 |
- |
|
Sir Andrew Likierman |
1,970 |
29,001 |
- |
|
Dambisa Moyo |
1,804 |
4,630 |
- |
|
Sir Michael Rake |
1,891 |
20,845 |
- |
|
Sir John Sunderland |
1,830 |
85,107 |
- |
¹ Reuben Jeffery's beneficial interest comprises 15,000 American Depositary Shares and 7,691 Ordinary Shares in Barclays PLC
This information is provided by RNS